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Abstract
Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an important secondary
prevention strategy to address substance use and depression risk beginning in youth and
continuing across the lifespan. Ten healthcare settings in Virginia implemented the SBIRT
model between 2017 and 2020. A total of 65,315 participants ages 18 and older were universally
screened to determine the severity of their substance use and depression and offered a riskinformed intervention. 12.7% of individuals endorsed some level of risky substance use and
4.5% screened positive for depression overall (11.1% in the outpatient setting). 10% of all brief
intervention recipients were enrolled for follow-up screening 6 months later. Younger adults had
significantly greater prevalence of risky drug use and depression compared to older age groups
while middle-age adults displayed higher prevalence of moderate to severe alcohol risk,
highlighting the need for early intervention among younger adults. Significant reductions were
observed in risky alcohol use (52.2%), as well as illicit drug use (44.7%) and depression
(63.0%).
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Changing the Trajectory of Substance Use and Depression Beyond the Formative Years:
The Virginia Screening, Brief Intervention, and Referral to Treatment Project
Introduction
Preventing onset of substance use before the age of 18 is critical to reducing rates of substance
use disorders (SUDs) and other subsequent problems later in life.1-3 The early years of a child’s
life, including early adolescence, are formative and can influence a child’s behavior, including
substance use, throughout adulthood.4 Despite primary prevention strategies targeting youth, not
every child or adolescent refrains from use. In 2019, almost 30% of 12th-graders reported using
alcohol over the last month, and almost 24% acknowledged illicit drug use.5
As youth transition into young adulthood and beyond and work to become contributing members
of society, their journey through young, middle-age, and older adulthood remains susceptible to
the onset and intensification of substance use and psychiatric conditions. Over 50% of adults 18
and over endorse having consumed alcohol within the past month. Nearly half of these
individuals engaged in binge drinking, and almost 25% of young adults and 10% of adults 26+
used illicit drugs during the past month.6 Substance use in our nation now accounts for 3 of the
top 10 public health problems rated by the Centers for Disease Control and Prevention (CDC).7
Tobacco is the single largest preventable cause of death in the US, with approximately 1 person
dying every 9 seconds from a tobacco-related disease and costs of over $300 billion annually.8
An estimated 88,000 people die from alcohol-related causes annually, making alcohol the third
leading preventable cause of death in the US with an associated cost of $249 billion annually.9 In
2018, 8.1 million Americans were diagnosed with an illicit drug use disorder and over 67,000
drug overdose deaths occurred.10,11
Depression, a common comorbidity of substance use, affects 20.6% of Americans at some point
in their lifetime, with the highest prevalence (14.4%) seen in transitional-aged youth 18-25.6
Nearly 58% of individuals experiencing depression have also experienced a SUD.12 Given the
impact of substance use and depressive disorders on individuals, families, and society, the U.S.
Preventive Services Task Force now recommends routine screening for alcohol, drug use, and
depression along with behavioral intervention for risky alcohol use in those 18 and over.13
Across these behavioral health indicators, risk is known to emerge at critical time points across
the lifespan, with the young adult years being recognized as a critical at-risk period.14
While significant resources have been provided by federal, state, and local agencies to address
the prevention and treatment of substance use and depressive disorders, the prevalence of these
conditions has remained fairly stable or risen in recent years.6 To turn this tide, we must expand
efforts by bridging the gap between primary and tertiary prevention. A secondary substance use
and depression prevention net for all life stages beyond the formative and adolescence years is
vital to identifying and intervening at the onset of risk to 1) enable these individuals to live their
fullest lives and 2) support them in their development as a possible future parent or family
member for our next generation.
Secondary prevention in the field of substance use and mental health is characterized by the early
identification of problematic use and mental health dysfunction paired with a risk-stratified
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intervention. The ability to accurately identify emerging substance use and depression risk
allows healthcare providers the opportunity for early intervention targeting risk reduction,
potentially offsetting the significant costs and multidimensional consequences of substance use
and depressive disorders.
The evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) model is a
public health, secondary prevention strategy providing quick assessment of risk, conversations
promoting behavior change, and facilitating access to specialty care. SBIRT is a widely
recognized strategy for early identification and intervention of substance misuse with firm
evidence for its effectiveness.15 While the most robust support for SBIRT exists for reducing and
ceasing alcohol and tobacco use,16,17 there is good and growing support for its effectiveness with
illicit drugs.18 SBIRT outcomes specific to depression are promising yet preliminary.17 The
purpose of this paper is to describe the risk of substance misuse and potential impact of SBIRT
implementation on substance use in 11 healthcare settings across 2 regions of the
Commonwealth of Virginia in a project titled Virginia SBIRT, which was funded by the
Substance Abuse and Mental Health Services Administration.
Methods
The mission of the Virginia SBIRT project was to change the trajectory of substance use and
depression management through early identification and management, preventing the onset of
negative sequelae for those in the beginning stages of substance misuse and mitigating further
harm for those in more advanced stages. Eleven healthcare settings spanning rural and urban
regions in high-intensity drug trafficking areas integrated SBIRT between 2017 and 2020.
Settings included 2 emergency departments, 1 urgent care center, 2 federally qualified health
clinics, 1 family practice, 1 student health clinic, 2 sexually transmitted infection clinics in health
departments, and 2 free clinics. Criteria for setting selection included 1) location in a high-need
region of Virginia, 2) interest in adopting SBIRT as an organizational strategy for substance use
prevention and management, and/or 3) serve a population at higher risk for substance use
including sexually transmitted clinics or higher education students. The Virginia SBIRT Project
was funded by the Substance Abuse and Mental Health Services Administration.
Virginia SBIRT medical settings integrated SBIRT into clinical workflows and electronic health
records through 5 sequential practice transformation phases: orientation, sustainability, training,
implementation, and evaluation. Sites were oriented to the rationale behind the importance of
SBIRT, and organizational champions were identified. Early strategic conversations occurred
around the best model for SBIRT sustainability within each site to inform clinical workflow
development. Multilevel and ongoing training prepared behavioral health (counselors, social
workers) and medical staff (physicians, nurse practitioners, physician assistants, nurses) to
develop SBIRT proficiency. The comprehensive training program included an experiential
workshop followed by ongoing coaching (observation with feedback), booster training sessions,
and optional participation in a monthly teleECHO clinic promoting case sharing with feedback.
The SBIRT framework was then implemented in a pilot phase that included a consistent and
systematic Rapid Cycle Quality Improvement and evaluation process assessing program impact
and provider experience.
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Adults ages 18 and over were universally screened for substance misuse (alcohol, marijuana,
illicit drugs, prescription drugs, tobacco/nicotine) and depression. Universal screening items
consisted of the 3-item US Alcohol Use Disorders Identification Test Consumption screen (US
AUDIT-C), 4 questions on drug use (1 for marijuana, 2 for prescription drugs, 1 for illicit drugs),
1 question on tobacco/nicotine use, and the 2-item Patient Health Questionnaire (PHQ-2) for
depression. Exceptions to universal screening were specific to emergency departments and
included: 1) triage into a rapid assessment unit, 2) medical instability, 3) psychiatric crisis, and 4)
workman’s compensation visits. In addition, within emergency departments, individuals
presenting with mental health symptoms were triaged to the behavioral health team, bypassing
the SBIRT process. The US AUDIT, 10-item Drug Abuse Screening Test (DAST-10), and PHQ9 were used as secondary screens for alcohol, drugs, and depression.
Total scores from secondary screens were stratified into low, moderate, and severe risk
categories. Risk-informed interventions were delivered based on risk category. The low-risk
intervention included a 5- to 15-minute Brief Intervention (BI) designed to enhance awareness of
the consequences of the risk behavior, provide personalized feedback related to this behavior,
elicit intrinsic desire and commitment for behavior change, and support individuals ready to
make a change in developing a plan in support of that change. The moderate-risk intervention
included a BI and offer to return to the medical setting for Brief Treatment (BT), which
comprised up to 12-15 individual therapy sessions using motivational enhancement and
cognitive behavioral therapy to support behavior change. The severe-risk intervention included a
BI designed to elicit commitment to engage in higher levels of care (eg, intensive outpatient,
residential, detoxification) and Referral to Treatment (RT), or active care coordination and
follow-up, to facilitate treatment engagement at specialty substance abuse/mental health
treatment facilities.
Participants were eligible to participate in the 6-month follow-up evaluation if they scored
positive for substance use risk and received an intervention of at least a BI. Recruitment occurred
at the time of initial screening and BI delivery. Participants were assured their decision to
participate would have no impact on current or future services and they would receive a $20 gift
card for completing the interview. Each site was required to recruit 10% of eligible participants
and was requested to do so using quasirandom methodology (eg, selecting every 10th person who
received an intervention for recruitment). As part of the continuous quality improvement process
with sites, data were reviewed monthly to examine 6-month follow-up recruitment to ensure that
a) at least 10% of eligible individuals were recruited, and that b) participants at varied levels of
risk and receiving varied levels of interventions were recruited.
Analyses included Chi-square tests to examine group differences by gender, age group, race, and
ethnicity. T-tests, generalized linear modeling (GLM), and regression were used to examine
changes over time in alcohol, drug, and depression risk. Outcome variables measuring risk
included the scores on the US AUDIT, DAST-10, and PHQ-9 as well as changes in risk category
membership (no, low, moderate, and severe risk).
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Results
Risk Prevalence
The project screened 65,315 unique, predominantly white and non-Latino individuals age 18 and
over, and 15.7% of individuals screened positive for at least one of the following behavioral
health risks: risky alcohol use, other drug use, and/or depression. 12.7% of individuals endorsed
some level of risky alcohol and/or drug use with 73.3% scoring as low risk, 17.1% moderate risk,
and 9.6% severe risk. 14.2 percent of those positive for alcohol or drug risk endorsed
polysubstance use. Cannabis and alcohol were the most common substances endorsed. Four
percent of people screened positive for depression risk (>5 on the PHQ-9), a rate limited by the
triaging of mental health-related presenting problems in emergency settings, thereby bypassing
SBIRT screening. Notably, when excluding the emergency department setting, the risk
prevalence rate for depression increased to 11.1%. There were several important demographic
differences across the 3 risk areas: alcohol, other drug use, and depression (Table 1).
Age. Across all behavioral health indicators, age was associated with level of risk. Younger
adults were at greatest risk for illicit drug use (ages 18-34) and depression (ages 18-24) whereas
middle-aged adults 34-65 displayed the highest levels of alcohol risk. 49.1% of those who
endorsed any alcohol and/or drug risk and 48.3% of those who endorsed any depression were in
the 18-34 age group.
Other Demographics. Males displayed higher levels of risk for alcohol and illicit drugs
compared to females. Notably, individuals who identify as transgender/nonbinary had
significantly higher levels of risk for alcohol (7.1%), illicit drugs (24.5%), and depression
(21.2%) among all gender categories. Racial and ethnic minority status was also associated with
risk. Individuals who identify as American Indian/Alaskan Native/Hawaiian showed higher
levels of risk across all 3 risk indicators. Black/African American individuals also displayed
higher levels of illicit drug risk, and individuals who identified as Hispanic/Latino and Asian had
higher rates of depression risk.
Intervention Delivery Rate
We examined the extent to which individuals identified as at risk received the appropriate riskstratified intervention. Individuals were most likely to receive the clinically indicated
intervention when they screened into the low risk range (BI, 56.8%) followed by referral to
specialty treatment (RT, 53.7%) and on-site brief treatment (BT, 13.4%). In examining
intervention delivery by demographic characteristics, a BI was the most commonly received
intervention across all age groups. Receipt of BT also remained stable across age groups.
Individuals were most likely to receive RT if they were older than 25 (X2=10.0, p<.04).
Regarding gender, males were more likely to receive an intervention (X2= 488.5, p<.0001) and
individuals who identified as Black/African American and American Indian/Alaskan
Native/Hawaiian were almost twice as likely to receive an intervention (X2= 232.8, p<.0001).
Individuals who identified as Hispanic or Latino also received interventions at a higher rate than
non-Hispanic individuals (X2= 111.6, p<.0001).
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Intervention Outcomes
402 individuals (10.0%) who received an intervention for risky alcohol and/or drug use were
recruited into the 6-month follow-up evaluation. Overall, the majority of individuals recruited
into follow-up were low risk and received a brief intervention (57.6%), followed by moderate
risk (23.1%) and severe risk (19.3%). Importantly though, within the moderate and severe risk
categories, a higher proportion of individuals consented to follow-up (20.1% and 15.5%,
respectively) compared to those at low risk (8.6%).
273 individuals (67.9%) who consented to follow-up completed a 6-month outcome evaluation
(eg, completers). This follow-up reassessed substance and depression risk, allowing comparisons
to risk profile changes at intake. The primary reason for not completing follow-up was an
inability to contact the individual due to invalid contact information or a lack of response. We
examined differences in levels of risk and intervention received among those eligible for followup who did not enroll (eg, not recruited), those who consented to but did not complete the 6month follow-up (eg, nonresponders) and completers. There were no significant differences
between individuals not recruited for follow-up and completers. Interestingly, nonresponders
were more likely to have greater risk and have received an RT compared to the other 2 groups.
Table 2 describes changes in alcohol, drug, and depression risk over time. One of every 2
(52.2%) individuals receiving an intervention for alcohol were either within recommended
drinking limits (36.6%) or had decreased their risk level (15.6%) 6 months later (n=147) (Table
2). Regression analyses demonstrated an overall effect of US AUDIT scores significantly
decreasing over time for an average of 5.8 units in a given individual’s score (F(1)=45.4,
p<.001). As age increased, individuals demonstrated greater decreases in their US AUDIT scores
over time (F(1)=8.2; p<.01).
One of every 3 individuals (34.3%) receiving an intervention for drug use were abstinent, and
another 10.5% had decreased their risk level 6 months later (n=181) (Table 2). No age effects
were observed in response to interventions for drug use. A greater proportion of Black/African
American individuals decreased to no drug use or abstinence compared to white individuals
(X2=8.5, p<.05) with Black/African American individuals 2.2 times more likely to decrease to no
drug risk compared to white individuals (95% CI:1.0–4.6; p<.05). Regression analyses
demonstrated significant decreases in DAST10 scores over time (F(2) = 34.1, p<.001), and
demographic variables were not significant, indicating that none of those factors predicted any
decreases in drug risk.
Three of every 5 individuals (63.0%) receiving a depression intervention were either at no risk
(44.4%) or had decreased their level of risk (18.6%) 6 months later (Table 2). GLM models for
depression would not converge due to the small sample size of those with depression risk at
intake (n=32).
When evaluating patient satisfaction at follow-up, over 71% of individuals agreed or strongly
agreed that they thought differently about their substance use, understood more about the
physical health effect of substance use, and planned to make changes to their substance use.
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Table 1. Virginia SBIRT Alcohol, Drug, and Depression Risk by Demographic Characteristics (N=65,315)
Select Individual
Characteristics
Gender
Male
Female
Other
Age Group
18 to 24
25 to 34
35 to 44
45 to 54
55 to 64
65 years or
older
Race
American
Indian/Alaskan
Native/HI
Asian
Black/African
American
White
Ethnicity
NonLatino/Latina

US AUDIT Risk

DAST10 Risk

PHQ9 Risk

Any risk

Low

Mod

Sev

Any risk

Low

Mod

Sev

Any risk

Low

Mod

Sev

9.6%*

5.9%

2.3%

1.3%

10.8%*

8.7%

1.4%

0.7%

3.9%

1.8%

0.9%

1.1%

3.6%

2.6%

0.6%

0.4%

6.3%

5.3%

0.6%

0.4%

5.1%

2.0%

1.4%

1.7%

7.1%*

4.5%

1.9%

0.6%

24.5%*

15.5%

7.7%

1.3%

21.1%*

6.6%

4.6%

9.9%

5.6%

4.6%

0.7%

0.3%

15.9%*

12.5%

2.9%

0.4%

7.1%*

2.7%

1.8%

2.6%

6.7%

4.7%

1.3%

0.8%

14.4%*

11.5%

1.6%

1.3%

6.0%

2.4%

1.6%

1.9%

7.5%*

4.2%

2.0%

1.4%

10.2%

8.5%

0.8%

1.0%

5.4%

2.4%

1.3%

1.7%

8.2%*

4.6%

2.0%

1.6%

6.7%

5.9%

0.5%

0.3%

5.5%

2.3%

1.4%

1.9%

8.1%*

4.6%

2.1%

1.3%

4.9%

4.5%

0.3%

0.1%

4.4%

1.9%

1.1%

1.4%

3.7%

2.7%

0.8%

0.2%

0.7%

0.7%

0.0%

0.0%

1.3%

0.6%

0.4%

0.3%

8.2%*

7.2%

1.0%

0.0%

18.7%*

14.4%

4.3%

0.0%

10.7%*

1.9%

3.9%

4.9%

3.1%*

2.5%

0.5%

0.1%

6.2%

4.6%

1.5%

0.1%

7.6%*

2.5%

2.0%

3.0%

6.2%

4.4%

1.4%

0.5%

15.7%*

13.6%

1.8%

0.3%

4.5%

1.3%

1.3%

1.9%

6.0%

4.0%

1.3%

0.8%

7.1%

6.0%

0.7%

0.4%

3.9%

1.8%

0.8%

1.2%

6.1%

4.1%

1.3%

0.7%

8.2%

6.8%

0.9%

0.4%

3.8%

1.7%

0.9%

1.3%

Latino/Latina

7.1%
5.2%
1.3%
0.6%
10.9%
8.5%
2.1%
0.3%
8.6%*
3.1%
2.3%
3.2%
Notes. Individuals could elect not to answer questions on race and ethnicity; 38% of individuals elected not to answer questions about race while 34% elected
not to answer questions about ethnicity. Emergency departments triaged individuals with mental health concerns to their behavioral health unit and therefore are
not included in the risk prevalence rates. Any risk refers to the total percent of individuals with low to severe risk. Mod = moderate risk; Sev = severe risk.
Values in bold and with an asterisk denote statistically significant differences among the categories for that demographic variable at p<.001.
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Table 2. Virginia SBIRT Alcohol, Drug, and Depression Risk Over Time Among Follow-up Individuals
Audit Score (n=147)
Change at Follow-up

DAST10 Score
(n=181)

PHQ9 Score (n=32)

n

%

n

%

n

%

No decrease

64

47.8%

95

55.2%

10

37.0%

Decrease to lower (but non-zero) risk

21

15.7%

18

10.5%

5

18.5%

Decrease to no risk
Missing

49
13

36.6%

59
9

34.3%

12
5

44.4%
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Discussion
The Virginia SBIRT project demonstrated change in individual trajectories of substance use and
depression across populations of all ages 18 and over and in a variety of settings in 2 regions of
Virginia. The need for SBIRT as a public health strategy for reducing or ceasing illicit drug use
was especially relevant to younger adults, who had a higher prevalence for drug use and
depression compared to older age groups. Middle-age adults with risky alcohol use had a greater
prevalence for moderate to severe risk of alcohol use highlighting the need to intervene earlier to
prevent the development of greater levels of risk. Young adults are moving through a stage
critical to personal and professional development, including academic preparation, career
initiation, and marriage and family development, and early intervention can increase the
likelihood of long-term success.
Notably, SBIRT also demonstrated reductions in illicit drug use and depression risk in addition
to the already established effect it can have on alcohol. In addition, few research studies have
examined the RT process and its subsequent outcomes. While intervention delivery rates varied
across substance risk severity (BI, 56.8; RT, 53.7%; BT, 13.4%), it should be noted that these
rates of RT and BT reflect situations in which the individual accepted RT. National estimates
suggest that approximately 10.6% of individuals who need SUD treatment actually receive it.6
Our findings highlight the importance of brief, motivationally informed interventions paired with
a rapid referral system, support with social determinant needs, and systematic follow-up in
acceptance of RT. Data presented in the current study were part of a community implementation
effort. Thus, the design did not include a comparison or control group, thereby limiting the
ability to draw a causal conclusion between the intervention and outcomes.
Another limitation of this study was that only 10% of individuals who received an intervention
for risky alcohol and/or drug use were recruited for a 6-month outcome evaluation. While a
greater proportion of individuals at moderate and severe risk were recruited into follow- up,
fewer of these individuals completed the follow-up interview compared to those at lower risk.
Thus, it is possible that those who participated in the outcome evaluation reflect a biased sample
of individuals initially at lower risk. Lastly, because the focus of the outcome evaluation was on
those who received intervention for risky substance, the number of those with co-occurring
depression was small, further limiting conclusions for depression outcomes.
Beyond age, gender and ethno-racial status significantly influenced behavioral health risk
prevalence, likelihood of receiving a clinical intervention, and intervention outcomes. While the
core components of the clinical intervention do not vary, it is possible that provider biases related
to gender and ethno-racial status may have informed which individuals were prioritized for
receipt of an intervention and how the intervention was delivered. Upon receipt of an
intervention, it is unclear why certain groups may have responded differently to the intervention.
These are 2 areas that deserve future research.
It is also important to mention the potential influence of environment on the results of this
project. All healthcare settings were located in high-intensity drug-trafficking areas where the
supply of illicit substances and access to them are greater than in regions of the country with
limited drug-trafficking opportunities. Other variables, such as overdose rates, within many of
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these counties are higher compared to state averages, indicating greater morbidity in these
areas.19
Prevalence for depression risk in this sample is lower than community prevalence rates due to
triage processes at select high-volume sites (ie, emergency departments) that immediately triaged
mental health-related presenting problems to a behavioral health intervention team, bypassing the
SBIRT screening process. Additional limitations of this study include 1) nonrandomized
selection of sites with a large portion of the sample coming from an emergency department
setting and 2) inability to control for risk factors such as previous trauma, genetic contributions,
and family and peer influence.
Implications
Practice
Results from the Virginia SBIRT project support SBIRT as a powerful strategy to enhance and
expand substance use prevention nets in both rural and urban communities. SBIRT as a public
health strategy is appealing in its capacity for flexible adaptation to fit unique target populations
and settings. In addition to the standard SBIRT delivery model used in this study, variations
targeting adolescents, pregnant and parenting women, and older adults have been established.20-22
The common sources of variation among these SBIRT derivatives include population-specific
screening tools, greater emphasis on involvement of caregivers or other support persons,
mandated reporting requirements, unique strategies for adapting to population-specific settings
(eg, schools, residential care facilities), and considerations for training a potentially more diverse
set of interventionists across these settings. Substance-specific (eg, cannabis, opioids)
considerations in effectively identifying and responding to risk are also emerging in SBIRT
models.23-25
In support of SBIRT’s expansion across the nation, the Substance Abuse and Mental Health
Services Administration (SAMHSA) and other agencies have created and made publicly
available a sizable number of resources to support SBIRT integration (eg, Addiction Technology
Transfer Center Network, Centers for Medicaid and Medicare Services). Resources include
implementation guides, guidance on facilitating the organizational change process, foundational
knowledge and interactive clinical skills trainings, clinical tools to support provider service
delivery, patient education materials to enhance awareness raising, and documentation and
reimbursement guides.
The results of our study highlight the large proportion of young adults ages 18-34 scoring
positive for alcohol, drug, and depression risk, particularly in the low to moderate risk categories.
Severity of risk increased with age with a higher representation of moderate and severe risk in
the older population. Therefore, thoughtful and innovative approaches to reaching the young
adult population are warranted. Organizations more likely to interface with the young adult
population during activities unique to this age range include parenting organizations,
obstetrics/gynecology clinics, career centers, institutions of higher education, places of
employment hiring new graduates, and others. They may be natural places to identify substance
use risk.
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Alcohol, drug, and depression risk in those identifying as transgender/nonbinary is remarkably
high in our study among all gender variables. These findings are in line with previously
established higher prevalence rates of abuse and addiction in these gender categories 26-28 A
number of emerging provider education opportunities to increase awareness of gender diversity
and to learn strategies for more competent care can be accessed through the CDC.29
Policy
Early intervention for substance use is recommended by a number of federal agencies. The most
recent National Drug Control Strategy, produced by the Office of National Drug Control Policy
in February 2020, addresses the importance of early identification and intervention for risky
substance use to help “interrupt the trajectory toward more chronic substance use disorders” and
recommends that screening opportunities to identify risky behaviors be “widespread.”30 The
Surgeon General of the United States recognizes screening for substance misuse in healthcare
settings as the “first step” in identifying risky behaviors.31 SAMHSA and the Health Resources
and Services Administration (HRSA) have funded SBIRT activities in different ways since 2003.
32
Screening adults for substance is recommended by the U.S. Preventive Services Task Force
national guidelines.33
In alignment with these federal recommendations, this paper highlights the impact of secondary
prevention efforts on reducing or ceasing substance risk and the need for SBIRT programs
targeting young adults. Efforts are underway nationwide to examine the value of extending
SBIRT into adolescence, with promising results demonstrating the program’s effectiveness
within this age range.21 To date, the American Academy of Pediatrics, Maternal Child Health
Bureau, and Society for Adolescent Medicine all recommend annual adolescent SBIRT
screening.34 Taking a lead on targeting SBIRT in youth, Massachusetts enacted a law requiring
each city, town, regional school district, charter school, or vocational school to verbally screen
students at 2 grade levels for substance use disorders and provide clinical interventions as
indicated. Schools are required to notify students’ parents/guardians and provide an opportunity
to opt out by written notification any time prior to the screening.35 This approach demonstrates
how schools are in a unique position to reach adolescents when they may not necessarily be
connected with the healthcare sector to receive screening and intervention for substance use.
In support of SBIRT service delivery, reimbursement has been made available for screening and
brief intervention (SBI) through commercial insurance, Medicare, and Medicaid.36 The common
commercial insurance and Medicaid current procedural terminology (CPT) codes for SBIRT
cover screening and brief intervention services for 15 to 30 minutes (CPT 99408) or greater than
30 minutes (CPT 99409). Importantly, the Centers for Medicare and Medicaid Services (CMS)
now supports states in providing any service covered by the state’s Medicaid plan to any student
enrolled in Medicaid,37 which opens doors for school-based SBIRT. To our knowledge, at least
one state, Colorado, has also obtained legislative support for a budget line item to provide
SBIRT training and technical assistance across the state (25.5-5-208 CRS).38
Conclusion
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SBIRT is an effective early intervention strategy for identifying and changing substance use and
depression trajectories for youth, young adults, and beyond. The Virginia SBIRT project notably
reduced or eliminated risk for illicit drug use (34%) and depression (63%) as well as alcohol
(52%). Results related to young adults in the 18 to 34 age range and those identifying as
transgender/nonbinary highlight demographic variables warranting continued and special
attention from substance use and depression prevention and treatment policy. Continued and
expanded funding for SBIRT within a variety of sectors is important. Federal, state, and local
support of implementation of SBIRT is critical to addressing substance misuse in the nation.
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